| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LivaNova PLC | President, Global Epilepsy | Stock Appreciation Rights | 15,385 | $1,262,185 | $82.04 | 30 Mar 2025 | Direct |
| LivaNova PLC | President, Global Epilepsy | Ordinary Shares | 12,751 | $498,947 | $39.13 | 30 Mar 2025 | Direct |
| LivaNova PLC | President, Global Epilepsy | Restricted Stock Units | 7,027 | $385,150 | $54.81 | 30 Mar 2025 | Direct |
| LivaNova PLC | President, Global Epilepsy | Performance Stock Units | 7,027 | 30 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LIVN | LivaNova PLC | 30 Mar 2025 | 14 | -$110,934 | 4 | President, Global Epilepsy | 01 Apr 2025, 21:01 |
| LIVN | LivaNova PLC | 30 Mar 2024 | 14 | -$203,789 | 4 | President, Global Epilepsy | 02 Apr 2024, 21:22 |
| LIVN | LivaNova PLC | 01 Mar 2024 | 0 | $0 | 3 | President, Global Epilepsy | 11 Mar 2024, 16:47 |